Sensydia

United States
Menasha, Wisconsin, United States, 90024

Company profile

Sensydia company profile

Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to gold standard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2015-01-01, Year

Headquarters

Postal code
90024
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$17.8M
Last funding
Grant / $3M / 2023-06-05
Last equity funding
Series Unknown / $8M
Investors
4
Lead investors
3
Founders
2
Articles
26

Founders and investors

Founders

Tom BruggereWilliam Kaiser

Lead investors

Colle Capital PartnersNational Heart, Lung and Blood InstituteOrlando Health Ventures

Investors

Colle Capital PartnersFrontier Venture CapitalNational Heart, Lung and Blood InstituteOrlando Health Ventures